Moving averages
SMA 200$2.52-5.56%
Company profile
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
SectorHealthcare
IndustryBiotechnology
Market cap$114.97M
P/E ratioNone
EPS$-2.22
Beta-0.84
Dividend yield0.00%
52-week high$3.45
52-week low$1.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
IMUX
Immunic Inc
RSI 40
NERV
Minerva Neurosciences Inc
RSI 32
CHRS
Coherus Biosciences Inc
RSI 34
CGTX
Cognition Therapeutics Inc
RSI 32
HRTX
Heron Therapeutics Inc
RSI 37
DTIL
Precision Biosciences Inc
RSI 56
RSI alerts for SAVA
An email when SAVA closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 31 October 2026 at 9:02 PM EDT